Hans Wang, who leads the Greater China and Asia cross-border teams at CVC Capital Partners, discusses uncertainty in China, the evolution of partnership and control strategies, and how to stay ahead in Asia
Q: Has CVC altered its approach to China given recent regulatory uncertainty in various industries? A: Long term, we are committed to China – it represents a huge opportunity, and we will continue...
Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has closed a Series C extension led by SummitView Capital. This brings the size of the overall round to USD 500m.
Japanese lower middle-market private equity firm J-Star has made an investment of undisclosed size in air cargo transportation and courier services provider Score Japan Holdings.
Gaorong Capital and Tsing Song Capital have led a CNY 500m (USD 74m) Series C for IntellectiveBio, a China-based contract development and manufacturing organisation (CDMO).
Morningside Venture Capital has teamed up with Kingray Capital, Trinity Innovation Fund, TigerYeah Capital, and FountainBridge Capital to provide USD 20m in angel and pre-Series A funding for Epigenic Therapeutics, a China-based gene editing specialist.